Answers are grounded in this paper and cite their sources.
Reveals that a high burden of gene mutations affects outcomes in favorable-risk acute myeloid leukemia, indicating a need for better risk assessment.
The presence of a single MRG mutation did not confer a worse prognosis in favorable-risk AML, whereas a high MRG mutation burden (≥2 mutations) was independently associated with poorer LFS. This study suggests that quantifying the MRG mutation burden may inform risk stratification in this patient population.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: